Theravance Biopharma Inc TBPH 深 沪
已收盘 08-07 16:00:00 美东时间
16.93
+0.010
+0.06%
华盛通- 最 高16.95
- 今 开16.92
- 成交量 29.36万股
- 最 低 16.86
- 昨 收 16.92
- 总市值 128.86万
- 52周最高 21.03
- 市盈率 静 --
- 换手率 385.70%
- 52周最低 13.08
- 委 比 85.66%
- 总股本 7.61万
- 历史最高 43.44
- 量 比 0.70
- 振 幅 0.53%
- 历史最低 1.10
- 每 手 1
- 风险率 2.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BTIG Downgrades Theravance Biopharma to Neutral
BTIG analyst Julian Harrison downgrades Theravance Biopharma (NASDAQ:TBPH) from Buy to Neutral.
06-29 23:31
Zymeworks Targets Long-Term Cash Generation Through Theravance Acquisition
Zymeworks will acquire Theravance Biopharma for $929 million, adding YUPELRI cash flows and expanding its portfolio.
06-29 21:20
Oppenheimer Downgrades Theravance Biopharma to Perform
Oppenheimer analyst Trevor Allred downgrades Theravance Biopharma (NASDAQ:TBPH) from Outperform to Perform.
03-06 01:59
Theravance Biopharma Plummets As Phase 3 Study Falls Short
Theravance Biopharma shares tumble after Phase 3 trial fails, company halts drug program and explores sale options ahead of earnings.
03-04 02:19
Crude Oil Surges Over 6%; Target Profit Tops Views
US stocks down amid Iran-US conflict. Tehran closed Strait of Hormuz & warned of firing on vessels. Dow down 2.45%, NASDAQ down 2.62%, S&P 500 down 2.34%.
03-04 01:14
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12
Unveiling 4 Analyst Insights On Theravance Biopharma
Across the recent three months, 4 analysts have shared their insights on Therav...
2024-09-16 20:00
HC Wainwright & Co. Reiterates Buy on Theravance Biopharma, Maintains $15 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Theravance Biopharma (NASDAQ:TBPH) with a Buy and maintains $15 price target.
2024-09-16 19:53
